Oct
04

Testosterone for Women: Current AACE Guidelines vs What the Literature Says

Testosterone for Women: Current AACE Guidelines vs What the Literature Says by Neal Rouzier, MD In Testosterone for Women Part 1: The Evidence and Benefits No One Talks About, I presented the studies/papers demonstrating that symptom improvement is only achieved with supraphysiologic levels of testosterone. Rebecca Glasser, a well-respected and published breast cancer surgeon, proves
DETAIL
Sep
07

Testosterone for Men: Facts, Figures and Literature that you Should Know Before Prescribing Testosterone

Testosterone for Men: Facts, Figures and Literature that you Should Know Before Prescribing Testosterone by Neal Rouzier, MD The more articles that demonstrate the benefits of testosterone, the more there is pushback against the use of testosterone. Every day I encounter a PMD or specialist that criticizes my use of testosterone, despite the fact that
By Neal Rouzier | Blog . Case Studies . Testosterone
DETAIL
Jul
29

Testing for Dementia and Successful Therapies After Diagnosis

Testing for Dementia and Successful Therapies After Diagnosis by Neal Rouzier, MD Alzheimer's Dementia Case Study Recently, I was asked to consult on a 70 y/o man who was diagnosed with AD. Ten years ago he was gainfully employed as an accountant but had rapidly progressive dementia thereby making work impossible, thus mandating retirement. After undergoing
DETAIL
Mar
09

How Hormones are Disrupting the Oncology Industry

Why is there increased morbidity and mortality in those that don’t take ERT? This is simply because there is an increase in breast cancer recurrence in prior cancer survivors, around 350/10,000 women (that don’t take HRT). This does not mean, though, that taking estrogen increases the risk. However, those that do take BHRT do benefit from HRT despite the resistance from oncologists. The increase in breast cancer recurrence at baseline should not be extrapolated to what happens with treatment. In every study, treatment with estrogen decreases breast cancer risk. Observation at baseline does not prove causation. The most recent issue of JAMA proved that the only drug to decrease breast cancer mortality was estrogen! It was not a SERM or AI.

By Neal Rouzier | Blog . Cancer . Case Studies . Disease
DETAIL